{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:32:42Z","timestamp":1776353562584,"version":"3.51.2"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Congenital nephrogenic diabetes insipidus (NDI) is a rare hereditary disorder caused by mutations in two critical genes: arginine vasopressin receptor 2 (AVPR2) and aquaporin 2 genes (AQP2). Mutations in AVPR2 gene, which are predominantly X-linked, account for a significant proportion of cases, particularly in men. Nevertheless, research on this condition in the western Chinese population remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Eleven participants from nine families with NDI were screened for AVPR2 mutations. Their clinical features were documented, and genotype\u2013phenotype associations were investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included 11 pediatric patients with congenital NDI, comprising 10 boys and 1 girl. They were diagnosed between 1\u2005month and 7\u2005years of age. The clinical presentations included growth retardation, polydipsia, and polyuria in all patients (11), hypernatremia in 10, renal pelvis dilation in 4, absence of posterior pituitary high signal on magnetic resonance imaging in 3, unexplained fever in 3, and recurrent vomiting in 1 and mental retardation each in 1 patient. Genetic analysis revealed eight AVPR2 mutations among the 11 patients with congenital NDI, 3 of which were novel: p.Ile46Serfs*145, p.Ile177del, and p.Ser327Ilefs*30.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In the largest case series of congenital NDI caused by AVPR2 mutations in the western Chinese population, eight AVPR2 mutations were identified, including three that were novel. This study enhances the existing literature by elucidating the clinical manifestations of congenital NDI by analyzing 11 cases and by identifying three novel mutation sites, thereby augmenting the genetic understanding of this condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2025.1623342","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:16:28Z","timestamp":1757312188000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel AVPR2 mutations in congenital nephrogenic diabetes insipidus: clinical characteristics and genetic analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Kunjiao","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanjie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1007\/s40618-021-01607-3","article-title":"Novel AVPR2 mutations and clinical characteristics in 28 Chinese families with congenital nephrogenic diabetes insipidus","volume":"44","author":"Li","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1297\/cpe.30.115","article-title":"Nephrogenic diabetes insipidus caused by a novel missense variant (p.S127Y) in the AVPR2 gene","volume":"30","author":"Maeyama","year":"2021","journal-title":"Clin Pediatr Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1097\/PEC.0000000000001438","article-title":"Nephrogenic diabetes insipidus in childhood: assessment of volume status and appropriate fluid replenishment","volume":"36","author":"Guarino","year":"2020","journal-title":"Pediatr Emerg Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ecl.2020.05.012","article-title":"Diabetes insipidus: an update","volume":"49","author":"Refardt","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/jcp.21552","article-title":"AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance","volume":"217","author":"Spanakis","year":"2008","journal-title":"J Cell Physiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1681\/ASN.2005040371","article-title":"Molecular biology of hereditary diabetes insipidus","volume":"16","author":"Fujiwara","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s00467-012-2118-8","article-title":"Congenital nephrogenic diabetes insipidus: the current state of affairs","volume":"27","author":"Wesche","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7073158","DOI":"10.1155\/2022\/7073158","article-title":"A novel missense mutation of arginine vasopressin receptor 2 in a Chinese family with congenital nephrogenic diabetes insipidus: x-chromosome inactivation in female CNDI patients with heterozygote 814A>G mutation","volume":"2022","author":"Zang","year":"2022","journal-title":"Biomed Res Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/ajmg.a.61516","article-title":"A female with X-linked nephrogenic diabetes insipidus in a family with inherited central diabetes insipidus: case report and review of the literature","volume":"182","author":"Ding","year":"2020","journal-title":"Am J Med Genet A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6561952","DOI":"10.1155\/2018\/6561952","article-title":"Four Japanese patients with congenital nephrogenic diabetes insipidus due to the AVPR2 mutations","volume":"2018","author":"Namatame-Ohta","year":"2018","journal-title":"Case Rep Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s12098-023-04513-z","article-title":"Nephrogenic diabetes insipidus in a 10-mo-old infant: complication of nephropathic cystinosis","volume":"90","author":"Singh","year":"2023","journal-title":"Indian J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41581-024-00897-z","article-title":"International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)","volume":"21","author":"Levtchenko","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1530\/EJE-10-0823","article-title":"Growth retardation in untreated autosomal dominant familial neurohypophyseal diabetes insipidus caused by one recurring and two novel mutations in the vasopressin-neurophysin II gene","volume":"164","author":"Brachet","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B14","first-page":"85","article-title":"Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan","volume":"57","author":"Fujimoto","year":"2014","journal-title":"Yonago Acta Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1515\/jpem-2022-0058","article-title":"Evaluation of the etiological and clinical characteristics of pediatric central diabetes insipidus","volume":"35","author":"Gasimova","year":"2022","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3760\/cma.j.cn112138-20200721-00689","article-title":"Clinical characteristics of congenital nephrogenic diabetes insipidus","volume":"60","author":"Zhang","year":"2021","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B17","doi-asserted-by":"publisher","first-page":"790194","DOI":"10.3389\/fped.2021.790194","article-title":"Clinical and functional characterization of a novel mutation in AVPR2 causing nephrogenic diabetes insipidus in a four-generation Chinese family","volume":"9","author":"Guo","year":"2021","journal-title":"Front Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1172\/JCI104657","article-title":"The mechanism of antidiuresis associated with the administration of hydrochlorothiazide to patients with vasopressin-resistant diabetes insipidus","volume":"41","author":"Earley","year":"1962","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/adc.80.6.548","article-title":"Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride","volume":"80","author":"Kirchlechner","year":"1999","journal-title":"Arch Dis Child"},{"key":"B20","first-page":"278","article-title":"Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus","volume":"55","author":"Bichet","year":"1994","journal-title":"Am J Hum Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/(SICI)1098-1004(1998)12:2%3C137::AID-HUMU16%3E3.0.CO;2-J","article-title":"C112r, W323S, N317K mutations in the vasopressin V2 receptor gene in patients with nephrogenic diabetes insipidus. Mutations in brief no. 165. Online","volume":"12","author":"Szalai","year":"1998","journal-title":"Hum Mutat"},{"key":"B22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s100380200002","article-title":"Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients","volume":"47","author":"Chen","year":"2002","journal-title":"J Hum Genet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1590\/S1807-59322009000500007","article-title":"Nephrogenic diabetes insipidus (NDI): clinical, laboratory and genetic characterization of five Brazilian patients","volume":"64","author":"Vaisbich","year":"2009","journal-title":"Clinics (Sao Paulo)"},{"key":"B24","first-page":"266","article-title":"Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus","volume":"55","author":"Wildin","year":"1994","journal-title":"Am J Hum Genet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00431-018-3132-z","article-title":"Novel and recurrent variants in AVPR2 in 19 families with X-linked congenital nephrogenic diabetes insipidus","volume":"177","author":"Joshi","year":"2018","journal-title":"Eur J Pediatr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1681\/ASN.V8121855","article-title":"Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus","volume":"8","author":"Vargas-Poussou","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1681\/ASN.V1161044","article-title":"Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus","volume":"11","author":"Arthus","year":"2000","journal-title":"J Am Soc Nephrol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1623342\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:45:37Z","timestamp":1761817537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1623342\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":27,"alternative-id":["10.3389\/fped.2025.1623342"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1623342","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"article-number":"1623342"}}